Company Active LTD

Company profile

Cyted Ltd

UK company 11478299, incorporated on 23 July 2018.

The Data-Driven Diagnostics Company | Cyted

Our unique approach combines expertise in gastrointestinal oncology, digital pathology and AI-driven biomarker discovery.

Company number
11478299
Incorporated
23 Jul 2018
Companies House status
Active

Company identity

Founded / incorporated
23 July 2018

Company number 11478299

Verify at Companies House
Legal name
CYTED LTD
Company type
Private Limited Company
Region
East of England
Registered address
GROUND FLOOR BUILDING 3 OLD SWISS
149 CHERRY HINTON ROAD
CAMBRIDGE
UNITED KINGDOM
CB1 7BX
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

6 levels 4 ultimate controllers Controls 1
1
Company Active LTD
Cyted Ltd
CRN 11478299
2
Direct controller Active LTD
3
Intermediate controller Active PLC
BGF Group PLC
CRN 10657226
4
Intermediate controller Active LTD
5
Intermediate controller Active LTD
6
Intermediate controller Active LTD
7
Intermediate controller Active LTD
8
Intermediate controller Active PLC
HSBC Bank PLC
CRN 00014259
9
Intermediate controller Active LTD
10
Intermediate controller Active LTD
11
Intermediate controller Active LTD
12
Ultimate controller Active PLC
HSBC Holdings PLC
CRN 00617987
13
Intermediate controller Active LTD
14
Ultimate controller Active PLC
Natwest Group PLC
CRN SC045551
15
Ultimate controller Active PLC
16
Ultimate controller Active PLC
Barclays PLC
CRN 00048839

Company events

Reference milestones and recent Companies House filing stream events.

5 events
30 Sep
2027

Accounts due

Accounts Due

Next accounts due date

05 Aug
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

22 Jul
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2025

Accounts filed

Accounts

Last accounts made up date

23 Jul
2018

Incorporated

Inception

Company registered at Companies House

Public funding

2 awards
First funded
2020
Funded years
2020, 2024
Age at first award
1 years

Projects

2024 Collaborative R&D Lead participant

QuBIE: Quantitative Biomarker Identification for Non-Endoscopic Prediction and Monitoring of Treatment Response in Eosinophilic Oesophagitis

1 Jan 2024 to 30 Jun 2025

Awarded
£398,284
Total cost £663,806

Eosinophilic oesophagitis (EoE) is a disease of the oesophagus ("food pipe") affecting tens of thousands of adults and children across the UK. Related to asthma, allergies and other chronic inflammatory conditions, this disease has been on the rise in the last decade. However, it can often take years and even several trips to A&E due to food getting stuck...

2020 Collaborative R&D

Project DELTA - integrateD diagnostic solution for EarLy deTection of oesophageal cAncer

1 Feb 2020 to 30 Apr 2023

Awarded
£1,062,858
Total cost £1,518,369

N/A

Product types

Collaborative R&D